1 Item1A. Risk Factors 39 Item 1B. Unresolved Staff Comments 70 Item 1C. Cybersecurity 70 Item 2. Properties 71 Item 3. Legal Proceedings 71 Item 4. Mine Safety Disclosures 71 Part II 72 Item 5. Market For Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 72 Item 6. [Reserved] 72 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 73 Item 7A. Quantitative and Qualitative Disclosures about Market Risk 80 Item ...
Q2 FY2026 — expected 2026-08-15
| Type | Subject | Detail | Quarter |
|---|---|---|---|
| topic_mention | UNCY | discussed_in_filing Artificial Intelligence | |
| topic_mention | UNCY | discussed_in_filing Cybersecurity | |
| topic_mention | UNCY | discussed_in_filing Trusted Computing | |
| topic_mention | UNCY | discussed_in_filing Blockchain & Crypto | |
| topic_mention | UNCY | discussed_in_filing Supply Chain | |
| topic_mention | UNCY | discussed_in_filing Regulation | |
| topic_mention | UNCY | discussed_in_filing Enterprise | |
| topic_mention | UNCY | discussed_in_filing Healthcare & Bio | |
| topic_mention | UNCY | discussed_in_filing Platform & Ecosystem | |
| topic_mention | UNCY | discussed_in_filing Sovereign & Government | |
| topic_mention | UNCY | discussed_in_filing Artificial Intelligence | |
| topic_mention | UNCY | discussed_in_filing Cybersecurity | |
| topic_mention | UNCY | discussed_in_filing Trusted Computing | |
| topic_mention | UNCY | discussed_in_filing Blockchain & Crypto | |
| topic_mention | UNCY | discussed_in_filing Supply Chain | |
| topic_mention | UNCY | discussed_in_filing Regulation | |
| topic_mention | UNCY | discussed_in_filing Enterprise | |
| topic_mention | UNCY | discussed_in_filing Healthcare & Bio | |
| topic_mention | UNCY | discussed_in_filing Platform & Ecosystem | |
| topic_mention | UNCY | discussed_in_filing Sovereign & Government |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-30 | 2025-12-31 | 0001213900-26-035903 | EDGAR | 80K words |
| 2025-03-31 | 2024-12-31 | 0001213900-25-025828 | EDGAR | — |
| 2024-03-28 | 2023-12-31 | 0001213900-24-027202 | EDGAR | — |
| 2023-03-31 | 2022-12-31 | 0001213900-23-024901 | EDGAR | — |
| 2022-03-31 | 2021-12-31 | 0001213900-22-016384 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-12 | 2025-09-30 | 0001213900-25-108600 | EDGAR | 30K words |
| 2025-08-14 | 2025-06-30 | 0001213900-25-076007 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0001213900-25-042943 | EDGAR | — |
| 2024-11-13 | 2024-09-30 | 0001213900-24-097118 | EDGAR | — |
| 2024-08-14 | 2024-06-30 | 0001213900-24-068565 | EDGAR | — |
| 2024-05-13 | 2024-03-31 | 0001213900-24-042298 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0001213900-23-086979 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0001213900-23-067230 | EDGAR | — |
| 2023-05-16 | 2023-03-31 | 0001213900-23-040161 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001213900-22-071557 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0001213900-22-048198 | EDGAR | — |
| 2022-05-12 | 2022-03-31 | 0001213900-22-025684 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-04-06 | 0001213900-26-040179 | EDGAR | 0K words |
| 2026-03-30 | 0001213900-26-035961 | EDGAR | — |
| 2025-11-14 | 0001213900-25-111045 | EDGAR | — |
| 2025-11-12 | 0001213900-25-108847 | EDGAR | — |
| 2025-10-28 | 0001213900-25-102790 | EDGAR | — |
| 2025-08-18 | 0001213900-25-077937 | EDGAR | — |
| 2025-08-15 | 0001213900-25-077497 | EDGAR | — |
| 2025-08-14 | 0001213900-25-076066 | EDGAR | — |
| 2025-07-08 | 0001213900-25-061936 | EDGAR | — |
| 2025-06-30 | 0001213900-25-059303 | EDGAR | — |
99 total filings indexed. 72 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001766140 |
| Ticker | UNCY |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report